Abstract:OBJECTIVE:To evaluate if the necrotic tumor tissue treated with microwave coagulation therapy (MCT) can sensitize dendritic cell (DCs), and if the sensitized DCs have the specific inhibit effect on tumor cell. METHODS:CT-26 tumor nodules planted percutaneously in BALB/c mice were treated with MCT. The treated tumor tissue was levigated and filtrates and the filtrate obtained was incubated with the DCs from marrow of the BALB/c mice to get sensitized DCs. The shape of the DCs was observed by the microscopy and the electron microscopy respectively and the immune phenotype was detected by flow cytometer. The ability of the DCs to induce proliferation of T cells was measured by (3)H-TdR incorporation assay. The cytotoxicity of CTL activated by the DCs was measured by (51)Cr release assay. The inhibition of the DCs on the growth of CT-26 tumor in the mice was observed. RESULTS:The DCs cultured with the filter from necrotic tissue of CT-26 tumor had the typical shape and immune phenotype of the sensitized DCs. The intensity of the sensitized DCs and the naive DC to stimulate T lymphocyte proliferation at the DC/T of 1:10 was 80 +/- 10 vs 10 +/- 5 (P < 0.01); and at the DC/T of 1:20 was 58 +/- 7 vs 9 +/- 3 (P < 0.01). The killing effect of specific CTLs on CT-26 cancer cells in the sensitized DCs and the naive DCs group were 13.6 +/- 2.5 vs 1.1 +/- 0.4 (P < 0.01) at the E/T of 10:1, 27.5 +/- 4.4 vs 1.4 +/- 0.4 (P < 0.01) at E/T 20:1, and 51.2 +/- 8.1 vs 1.4 +/- 0.5 (P < 0.01) at the E/T of 50:1 respectively. The specific CTL's killing effect on MIP/ND4 lymphoma cells in the sensitized DCs and the naive DCs group were 2.61 +/- 0.64 vs 0.87 +/- 0.15 (P > 0.01) at the E/T of 10:1, 5.22 +/- 0.65 vs 2.18 +/- 0.41 (P > 0.01)at the E/T of 20:1, and 6.09 +/- 0.83 vs 3.91 +/- 0.51 (P > 0.01) at the E/T of 50:1 respectively. The difference of the volumes of the tumor implanted percutaneously in the BALB/c mice became more and more obviously with the prolongation of mice survival times in the sensitized DC group, the naive DC group and the control group. The weight of the tumor at the fortieth day were 4.5 g +/- 1.1 g, 6.9 g +/- 1.6 g, 9.0 g +/- 1.5 g in the three groups respectively (P < 0.01). Finally the special killing effect of the T cells which extracted from the spleen of the mice whose tumor had been treated by the sensitized DCs in vivo and in vitro were observed. CONCLUSION:As an whole cell antigen, the necrotic CT-26 tumor tissue treated with MCT can sensitize DCs, and the sensitized DCs have the specific inhibitory effect on CT-26 tumor cells both in vivo and in vitro.

Cytotoxic Effect of TGF-β Insensitive Dendritic Cell Vaccine on Cytotoxic T Lymphocytes in Mice with Renal Cell Carcinoma

Vaccination with Transforming Growth Factor-Beta Insensitive Dendritic Cells Suppresses Pulmonary Metastases of Renal Carcinoma in Mice

Therapeutic Effect of MIP-1alpha-recruited Dendritic Cells on Preestablished Solid and Metastatic Tumors.

Immunotherapeutic efficacy of transforming growth factor-beta insensitive dendritic cell vaccine in mice with renal carcinoma

Effect of blocking the transforming growth factor-beta signaling pathway on tumor-specific cytotoxic T lym-phocytes

Dendritic Cells Loaded with Ultrasound-Ablated Tumour Induce in Vivo Specific Antitumour Immune Responses

Adoptive Transfer of Tumor-Reactive Transforming Growth Factor-β–Insensitive Cytolytic T Cells for Treatment of Established Mouse Renca Tumors

TGF-β insensitive dendritic cells: an efficient vaccine for murine prostate cancer

Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor Beta-Insensitive CD8(+) T Cells

A Randomized Controlled Trial of Postoperative Tumor Lysate-Pulsed Dendritic Cells and Cytokine-Induced Killer Cells Immunotherapy in Patients with Localized and Locally Advanced Renal Cell Carcinoma.

Gemcitabine Treatment Enhanced the Anti-Tumor Effect of Cytokine Induced Killer Cells by Depletion of CD4+CD25bri Regulatory T Cells

Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma

Experimental study on the induction of cytotoxic T lymphocyte killing effects and dendritic-cell-based tumor vaccine prepared by high-intensity focused ultrasound

[Immunotherapy against tumor with dendritic cell sensitized by necrotic tumor tissue after microwave coagulation therapy].

Effects of dendritic cells co-cultured with CIK cells on renal carcinoma cells

[Controlled Live Dendritic Cell Vaccine Mediates Potent Antitumor Immune Responses].

Irradiation enhances dendritic cell potential antitumor activity by inducing tumor cell expressing TNF-α

Dendritic Cell Immunotherapy Induces Anti-Tumor Effect in a Transgenic Mouse Model of Pancreatic Ductal Adenocarcinoma.

Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy

Inhibitory Effects of a Dendritic Cell Vaccine Loaded with Radiation-Induced Apoptotic Tumor Cells on Tumor Cell Antigens in Mouse Bladder Cancer.

Dendritic Cells Vaccines Activated by Combined Toll-like Receptor Llgands Inhibit Murine Colon Cancer in Vivo